Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 8
1966 7
1967 14
1968 7
1969 13
1970 8
1971 15
1972 14
1973 6
1974 14
1975 7
1976 8
1977 6
1978 12
1979 5
1980 4
1981 7
1982 8
1983 11
1984 8
1985 12
1986 8
1987 13
1988 13
1989 6
1990 10
1991 10
1992 9
1993 7
1994 4
1995 8
1996 4
1997 11
1998 12
1999 6
2000 7
2001 19
2002 17
2003 21
2004 53
2005 58
2006 54
2007 70
2008 67
2009 99
2010 84
2011 114
2012 98
2013 111
2014 129
2015 166
2016 197
2017 183
2018 187
2019 228
2020 272
2021 336
2022 355
2023 302
2024 69

Text availability

Article attribute

Article type

Publication date

Search Results

3,109 results

Results by year

Filters applied: . Clear all
Page 1
Faricimab: First Approval.
Shirley M. Shirley M. Drugs. 2022 May;82(7):825-830. doi: 10.1007/s40265-022-01713-3. Drugs. 2022. PMID: 35474059 Review.
Pharmacologic therapy for diabetic retinopathy.
Gardlik R, Fusekova I. Gardlik R, et al. Semin Ophthalmol. 2015 Jul;30(4):252-63. doi: 10.3109/08820538.2013.859280. Epub 2014 Feb 27. Semin Ophthalmol. 2015. PMID: 24571780 Review.
Angiogenic footprints in diabetic retinopathy: opportunities for drug development.
Bhatia S, Babbar R, Zehravi M, Singh B, Chandel P, Hasan MM, Arora R, Gill NS, Sindhu RK, Ahmad Z, Khan FS, Rahman MH. Bhatia S, et al. Biotechnol Genet Eng Rev. 2023 Apr;39(1):118-142. doi: 10.1080/02648725.2022.2102880. Epub 2022 Jul 25. Biotechnol Genet Eng Rev. 2023. PMID: 35876332 Review.
Drug, delivery and devices for diabetic retinopathy (3Ds in DR).
Nirmal J, Radhakrishnan K, Moreno M, Natarajan JV, Laude A, Lim TH, Venkatraman S, Agrawal R. Nirmal J, et al. Expert Opin Drug Deliv. 2016 Nov;13(11):1625-1637. doi: 10.1080/17425247.2016.1188800. Epub 2016 May 30. Expert Opin Drug Deliv. 2016. PMID: 27169870 Review.
Anti-inflammatory therapy for diabetic retinopathy.
Zhang W, Liu H, Rojas M, Caldwell RW, Caldwell RB. Zhang W, et al. Immunotherapy. 2011 May;3(5):609-28. doi: 10.2217/imt.11.24. Immunotherapy. 2011. PMID: 21554091 Free PMC article. Review.
Potential drug interventions for diabetic retinopathy.
Shen Q, Wu JZ, Wong JC. Shen Q, et al. Drug Discov Today. 2013 Dec;18(23-24):1334-41. doi: 10.1016/j.drudis.2013.08.018. Epub 2013 Sep 5. Drug Discov Today. 2013. PMID: 24012972 Review.
3,109 results